What changed today in Regulatory: 1 recall record, 1 Federal Register notice
Every new official record on the Pharmacy, Compounding & Regulatory Intelligence desk since this morning, each linked to its primary source.
The signal
NPHLA tracked 2 new official records on this desk today: 1 recall record, 1 Federal Register notice.
Why this matters
Federal Register documents and FDA notices can change compliance obligations, deadlines and enforcement priorities for pharmacies, compounders and prescribers.
What changed
- Recall: Family Farmstead Dairy Announces Recall of All Cheddar Cheese Products Because of Possible Health Risk — reason given: not stated (firm: not stated).[1]
- Federal Register notice published: Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and….[2]
- Also reported by American Med Spa Association: “FDA Requires New Safety Warning on GLP-1 Medications for Rare Eye Condition”.[3]
Who this affects
- Pharmacies
- 503A compounders
- 503B outsourcing facilities
- Pharmacists
- Prescribers
- Practice owners & operators
What to watch next
No new verified deadlines in today’s records. See Deadline Watch for upcoming dates.
NPHLA takeaway
These are factual summaries of official records with no interpretation. Open the primary documents for full details; NPHLA editors add analysis where developments warrant it.
Source file
- [1]
- [2]
- [3]
Compiled automatically from primary official sources and peer-reviewed literature. Each line is a factual summary of a public record, linked to it — no interpretation is added. NPHLA links to sources and does not republish their text. Professional information only — not medical, legal or regulatory advice for any individual situation. Our standards.
Update timeline
- First published.
- Added 1 new official record.